Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride
- PMID: 20577787
- DOI: 10.1007/s11095-010-0191-x
Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride
Abstract
Purpose: Transdermal delivery of drugs is often limited by formidable barrier properties of stratum corneum (SC). Microneedles (MN) enable creation of transient microchannels in the SC and bypass this barrier. Many reports have focused on the great effectiveness of MN in improving percutaneous flux values of a variety of drugs over a large molecular size spectrum. The objective of the present study is to evaluate the influence of formulation on MN-enhanced transdermal transport of naltrexone hydrochloride (NTX HCl).
Methods: A series of in vitro experiments employing binary mixtures of propylene glycol (PG) and water as vehicle were used with either MN-treated or untreated skin. A simple model taking into account two parallel flux values through intact skin and microchannels was used to analyze data.
Results: Transdermal permeation of NTX HCl from different donor solutions indicated that PG-rich formulations greatly limited MN-enhanced transport but had a much smaller effect on transport through intact skin.
Conclusions: Diffusion through the microchannel pathway seems to be donor viscosity-related and follows the relationship predicted by the Stokes-Einstein equation as shown by linear dependence of flux on diffusivity of NTX in donor solutions.
Similar articles
-
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.J Control Release. 2010 Aug 17;146(1):37-44. doi: 10.1016/j.jconrel.2010.05.034. Epub 2010 Jun 4. J Control Release. 2010. PMID: 20678989 Free PMC article.
-
Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin.J Pharm Sci. 2012 Aug;101(8):2777-86. doi: 10.1002/jps.23189. Epub 2012 May 24. J Pharm Sci. 2012. PMID: 22628183
-
Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.Pharm Res. 2008 Jul;25(7):1677-85. doi: 10.1007/s11095-008-9578-3. Epub 2008 May 1. Pharm Res. 2008. PMID: 18449628 Free PMC article.
-
Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.Expert Opin Drug Deliv. 2010 May;7(5):617-29. doi: 10.1517/17425241003663228. Expert Opin Drug Deliv. 2010. PMID: 20205604 Free PMC article. Review.
-
Microneedles for transdermal drug delivery: a minireview.Front Biosci. 2008 Jan 1;13:1711-5. doi: 10.2741/2794. Front Biosci. 2008. PMID: 17981662 Review.
Cited by
-
Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics.Int J Pharm. 2012 Nov 15;438(1-2):140-9. doi: 10.1016/j.ijpharm.2012.08.026. Epub 2012 Aug 30. Int J Pharm. 2012. PMID: 22960319 Free PMC article.
-
Thermosensitive biomaterial gels with chemical permeation enhancers for enhanced microneedle delivery of naltrexone for managing opioid and alcohol dependency.Biomater Sci. 2023 Aug 22;11(17):5846-5858. doi: 10.1039/d3bm00972f. Biomater Sci. 2023. PMID: 37455601 Free PMC article.
-
Microneedles: Characteristics, Materials, Production Methods and Commercial Development.Micromachines (Basel). 2020 Oct 27;11(11):961. doi: 10.3390/mi11110961. Micromachines (Basel). 2020. PMID: 33121041 Free PMC article. Review.
-
Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.Mol Pharm. 2013 Jun 3;10(6):2331-9. doi: 10.1021/mp3007083. Epub 2013 May 13. Mol Pharm. 2013. PMID: 23590208 Free PMC article.
-
Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.Pharm Res. 2014 Jan;31(1):148-59. doi: 10.1007/s11095-013-1147-8. Epub 2013 Aug 14. Pharm Res. 2014. PMID: 23943543 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources